Investors looking for companies that will benefit most from the end of lockdowns should look past the obvious potential winners to dentists, car dealerships and malt producers.
Health by CITY BEAT Anthony Marx 16th Mar 2021 8:42 PM
Premium Content BIOTECH WINDFALL A promising Brisbane biotech outfit focused on fighting cancer has just launched its biggest capital raising to date, aiming to rustle up $75m. Loss-making QBiotics Group revealed on Tuesday that it had already secured $50m of the dough from Sydney-based fund manager TDM Growth Partners, which is now considered a cornerstone investor. Existing stakeholders have also been invited to tip in more at 90 cents a share, the same price forked out by TDM. The cash infusion comes at a critical juncture for the company, which launched in 2004 and has only recently started commercialising one of its products overseas.
Cancer-fighting Brisbane biotech chases $75m top-up byronnews.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from byronnews.com.au Daily Mail and Mail on Sunday newspapers.